Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study.

Neuroscience letters - 22 May 1998

Slooter A J, de Knijff P, Hofman A, Cruts M, Breteler M M, Van Broeckhoven C, Havekes L M, van Duijn C M

Abstract excerpt

The APOE*4 allele of the apolipoprotein E gene (APOE) is an important risk factor for Alzheimer's disease. It has been suggested that levels of apolipoprotein E (apoE) in plasma are increased in Alzheimer's disease. In this population-based study, we found that serum apoE levels were lower in Alzheimer patients compared to non-demented controls (0.75 micromol/l (SD 0.35), vs. 0.83 micromol/l (SD 0.40), P < 0.05)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Cohort Studies

Share to APOE gene

Share to Genotype

Source

Identifiers

PMID: 9665654
DOI: 10.1016/s0304-3940(98)00339-5

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study.PMID 9665654Read ↗

Apolipoprotein E genotype and progression of Alzheimer's disease: the Rotterdam Study.Semantic proximity Read ↗

Serum apolipoprotein E is associated with long-term risk of Alzheimer's disease: The Rotterdam Study.Semantic proximity Read ↗

Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group.Semantic proximity Read ↗

Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.Semantic proximity Read ↗

Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians.Semantic proximity Read ↗

Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.Semantic proximity Read ↗

Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.Semantic proximity Read ↗

The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease.Semantic proximity Read ↗

Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review.Semantic proximity Read ↗

Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis.Semantic proximity Read ↗

The effect of apolipoprotein E genotype on biochemical markers of Alzheimer's disease.Semantic proximity Read ↗

Plasma concentrations of the amyloid-β peptides in young volunteers: the influence of the APOE genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.